Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3

Author: Storey Robert   Melissa Thornton S.   Lawrance Rachael   Husted Steen   Wickens Mark   Emanuelsson Håkan   Cannon Christopher   Heptinstall Stan   Armstrong Martin  

Publisher: Informa Healthcare

ISSN: 1369-1635

Source: Platelets, Vol.20, Iss.5, 2009-08, pp. : 341-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract